{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:15Z","timestamp":1791216495999,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.thromres.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T05:48:13Z","timestamp":1663393693000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19"],"prefix":"10.1016","volume":"219","author":[{"given":"Luca","family":"Quartuccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Sonaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Casarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Di Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pegolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.thromres.2022.09.012_bb0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2022.09.012_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2020.08.011","article-title":"The novel coronavirus Disease-2019 (COVID-19): mechanism of action, detection, and recent therapeutic strategies","volume":"551","author":"Seyed Hosseini","year":"2020","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.thromres.2022.09.012_bb0015","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/jcm9061753","article-title":"COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge","volume":"9","author":"Baj","year":"2020","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.012_bb0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11739-020-02364-6","article-title":"The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies","volume":"15","author":"Albini","year":"2020","journal-title":"Intern. Emerg. Med."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.012_bb0025","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.012_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00428-021-03053-1","article-title":"The pulmonary pathology of COVID-19","volume":"478","author":"B\u00f6sm\u00fcller","year":"2021","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.012_bb0035","first-page":"233","article-title":"Tasso di embolia polmonare acuta nei pazienti ospedalizzati per COVID-19 in Italia. Metanalisi aggregata [Incidence of acute pulmonary embolism in hospitalized COVID-19 Italian patients. A pooled meta-analysis]","volume":"23","author":"Zuin","year":"2022","journal-title":"G Ital Cardiol"},{"key":"10.1016\/j.thromres.2022.09.012_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2022.01.051","article-title":"Prevalence of acute pulmonary embolism at autopsy in patients with COVID-19","volume":"171","author":"Zuin","year":"2022","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148435","article-title":"A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients","volume":"6","author":"Morrissey","year":"2021","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.012_bb0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jclinpath-2020-206995","article-title":"Histopathological observations in COVID-19: a systematic review","volume":"74","author":"Deshmukh","year":"2021","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.thromres.2022.09.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250708","article-title":"Pathological findings in organs and tissues of patients with COVID-19: a systematic review","volume":"16","author":"Peiris","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.thromres.2022.09.012_bb0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000515104","article-title":"Systematic review of microthrombi in COVID-19 autopsies","volume":"144","author":"Parra-Medina","year":"2021","journal-title":"Acta Haematol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.012_bb0065","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.012_bb0070","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1053\/j.jvca.2021.01.011","article-title":"Pulmonary vascular thrombosis in COVID-19 pneumonia","volume":"35","author":"De Cobelli","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.thromres.2022.09.012_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"issue":"23","key":"10.1016\/j.thromres.2022.09.012_bb0080","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2022.09.012_bb0085","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.012_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mpdhp.2020.11.008","article-title":"COVID-19 autopsies: conclusions from international studies","volume":"27","author":"Sekhawat","year":"2021","journal-title":"Diagn. Histopathol. (Oxf.)"},{"issue":"11","key":"10.1016\/j.thromres.2022.09.012_bb0095","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41374-020-0464-x","article-title":"Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents","volume":"100","author":"Best Rocha","year":"2020","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.012_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11845-021-02638-8","article-title":"Postmortem pathological changes in extrapulmonary organs in SARS-CoV-2 rt-PCR-positive cases: a single-center experience","volume":"191","author":"Bugra","year":"2022","journal-title":"Ir. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.012_bb0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.thromres.2022.09.012_bb0110","first-page":"1670","article-title":"Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports","volume":"25","author":"Dwiputra Hernugrahanto","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.thromres.2022.09.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120602","article-title":"Megakaryocytes in pulmonary diseases","volume":"301","author":"Huang","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.012_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00428-021-03053-1","article-title":"The pulmonary pathology of COVID-19","volume":"478","author":"B\u00f6sm\u00fcller","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.thromres.2022.09.012_bb0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","article-title":"Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the International COVID-19 Thrombosis Biomarkers Colloquium","volume":"19","author":"Gorog","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.012_bb0130","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2665-9913(21)00322-2","article-title":"Therapeutic implications of ongoing alveolar viral replication in COVID-19","volume":"4","author":"McGonagle","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.thromres.2022.09.012_bb0135","article-title":"Arterial thrombotic events in hospitalized COVID-19 patients: a short review and meta-analysis","volume":"6","author":"Candeloro","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.012_bb0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.012_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center,clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.012_bb0155","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","article-title":"The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli","volume":"10","author":"Chernysh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2022.09.012_bb0160","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","article-title":"Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1\u03b1 and cathepsin G","volume":"38","author":"Folco","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2022.09.012_bb0165","article-title":"Thromboinflammation: from atherosclerosis to COVID-19","volume":"8","author":"Wagner","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.thromres.2022.09.012_bb0170","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jth.15179","article-title":"Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia","volume":"19","author":"Nicolai","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.09.012_bb0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2021.10.001","article-title":"Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group","volume":"96","author":"Cacciapaglia","year":"2022","journal-title":"Eur. J. Intern. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.012_bb0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","article-title":"Vascular Beh\u00e7et's syndrome: an update","volume":"14","author":"Emmi","year":"2019","journal-title":"Intern. Emerg. Med."},{"issue":"Suppl 3","key":"10.1016\/j.thromres.2022.09.012_bb0185","doi-asserted-by":"crossref","first-page":"iii101","DOI":"10.1093\/rheumatology\/kez626","article-title":"Beh\u00e7et: the syndrome","volume":"59","author":"Bettiol","year":"2020","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.thromres.2022.09.012_bb0190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl 3","key":"10.1016\/j.thromres.2022.09.012_bb0195","doi-asserted-by":"crossref","first-page":"iii108","DOI":"10.1093\/rheumatology\/keaa086","article-title":"Management of Behcet's syndrome","volume":"59","author":"Karadag","year":"2020","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.thromres.2022.09.012_bb0200","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2665-9913(21)00216-2","article-title":"Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis","volume":"3","author":"Kyriazopoulou","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.012_bb0205","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.thromres.2022.09.012_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243961","article-title":"Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: a cohort study","volume":"15","author":"Borie","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2022.09.012_bb0215","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3389\/fimmu.2020.01625","article-title":"Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies","volume":"11","author":"Bonaventura","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2022.09.012_bb0220","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.mayocp.2020.04.027","article-title":"Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)","volume":"95","author":"Vijayvargiya","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"6","key":"10.1016\/j.thromres.2022.09.012_bb0225","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1016\/S2665-9913(21)00070-9","article-title":"Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial","volume":"3","author":"Cremer","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"8","key":"10.1016\/j.thromres.2022.09.012_bb0230","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/S2665-9913(20)30170-3","article-title":"GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study","volume":"2","author":"De Luca","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.012_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261786","article-title":"COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: insights from a large US cohort","volume":"17","author":"Ward","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.012_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cjp2.189","article-title":"Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza a: autopsy results from 'Spanish flu' 1918\/1919 in Switzerland to coronavirus disease 2019","volume":"7","author":"Burkhard-Koren","year":"2021","journal-title":"J. Pathol. Clin. Res."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.012_bb0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center,clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.thromres.2022.09.012_bb0250","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2022.09.012_bb0255","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1740774520943846","article-title":"Anti-thrombotic therapy to ameliorate complications of COVID-19 (ATTACC): study design and methodology for an international, adaptive Bayesian randomized controlled trial","volume":"17","author":"Houston","year":"2020","journal-title":"Clin. Trials"},{"issue":"9","key":"10.1016\/j.thromres.2022.09.012_bb0260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10319","key":"10.1016\/j.thromres.2022.09.012_bb0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"},{"issue":"10320","key":"10.1016\/j.thromres.2022.09.012_bb0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.thromres.2022.09.012_bb0275","first-page":"161","article-title":"Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?","volume":"131","author":"Calcaterra","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2022.09.012_bb0280","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000924","article-title":"Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"5","author":"Tektonidou","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.thromres.2022.09.012_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100434","article-title":"Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series","volume":"24","author":"Rapkiewicz","year":"2020","journal-title":"EClinicalMedicine"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T02:41:47Z","timestamp":1743648107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"alternative-id":["S0049384822003929"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.09.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}